Fury as NHS rejects cystic fibrosis drug price offer
Vertex ‘astonished and dismayed’ by NHS rejection
Vertex wants long-term funding for CF research
Vertex is trying reach a deal with NHS England to give patients access to all its approved cystic fibrosis (CF) drugs – and hopes it could also fund further drugs in the pipeline.
Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.